Hsieh, Chang-Yu
Tsai, Tsen-Fang https://orcid.org/0000-0002-1498-1474
Article History
Accepted: 25 July 2022
First Online: 14 August 2022
Declarations
:
: No funding or sponsorship was received for this study.
: Chang-Yu Hsieh has no conflict of interest to disclose. Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli-Lilly, Galderma, Janssen-Cilag, Merck Sharp & Dohme, Novartis International AG, Pfizer Inc., and UCB Pharma.
: This article is based on previously conducted studies. Searching strategies are specified in the Methods section.
: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
: This article is based on previously conducted studies and does not contain any studies with human participants.
: Dr Chang-Yu Hsieh conducted the literature search, summarized the identified papers and drafted the manuscript. Dr Tsen-Fang Tsai is responsible for the ideation of this topic and final refinement of this article.